ICU Medical
ICUI
260 hedge funds and large institutions have $3.06B invested in ICU Medical in 2019 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 105 increasing their positions, 73 reducing their positions, and 51 closing their positions.
340% more call options, than puts
Call options by funds: $22.5M | Put options by funds: $5.11M
44% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 73
1.91% less ownership
Funds ownership: 94.74% → 92.83% (-1.9%)
4% less funds holding
Funds holding: 270 → 260 (-10)
20% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 51
38% less capital invested
Capital invested by funds: $4.92B → $3.06B (-$1.85B)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$99.7M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$54.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$48.1M |
| 4 |
NC
Nitorum Capital
New York
|
+$44.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$44.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$171M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$97.9M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$97.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$60.9M |
| 5 |
Millennium Management
New York
|
-$42.9M |
ICUI Hedge Fund Activity: Q3 2019 in Review
260 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q3 2019, worth a combined $3.06B — down 38% from $4.92B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of ICUI and 41 opened new positions — a net loss of 10 holders — while 73 trimmed existing stakes and 105 added.
The largest buyer was Nuance Investments, adding an estimated $99.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $171M.
- 260 institutional investors held ICU Medical (ICUI) as of Q3 2019, down from 270 in Q2 2019.
- Funds reported $3.06B of ICU Medical stock for Q3 2019, down 38% quarter-over-quarter.
- 41 funds opened new ICU Medical positions in Q3 2019 and 51 closed out, a net change of -10 holders.
- The largest ICU Medical buyer in Q3 2019 was Nuance Investments, an estimated $99.7M added.
- The largest ICU Medical seller in Q3 2019 was T. Rowe Price Associates, an estimated $171M sold.
Based on aggregated 13F filings for Q3 2019.